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We determined norovirus (NoV) concentrations in effluent from a wastewater treatment plant and in oysters during the peak
period of laboratory-confirmed cases of NoV infection in Ireland in 2010 (January toMarch). Weekly samples of influent, sec-
ondary treated effluent, and oysters were analyzed using real-time quantitative reverse transcription-PCR for NoV genogroup I
(GI) and genogroup II (GII). The mean concentration of NoV GII (5.87 104 genome copies 100 ml1) in influent wastewater
was significantly higher than the mean concentration of NoV GI (1.40 104 genome copies 100 ml1). The highest concentra-
tion of NoV GII (2.20 105 genome copies 100 ml1) was detected in influent wastewater during week 6. Over the study period,
a total of 931 laboratory-confirmed cases of NoV GII infection were recorded, with the peak (n 171) occurring in week 7. In
comparison, 16 cases of NoV GI-associated illness were reported during the study period. In addition, the NoV capsid N/S do-
main was molecularly characterized for selected samples. Multiple genotypes of NoV GI (GI.1, GI.4, GI.5, GI.6, and GI.7) and GII
(GII.3, GII.4, GII.6, GII.7, GII.12, GII.13, and GII.17), as well as 4 putative recombinant strains, were detected in the environ-
mental samples. The NoV GII.4 variant 2010 was detected in wastewater and oyster samples and was the dominant strain de-
tected in NoV outbreaks at that time. This study demonstrates the diversity of NoV genotypes present in wastewater during a
period of high rates of NoV infection in the community and highlights the potential for the environmental spread of multiple
NoV genotypes.
Norovirus (NoV) is the leading cause of acute gastroenteritisoutbreaks in Ireland (1) and is responsible for an estimated
90% of all epidemic nonbacterial outbreaks of gastroenteritis
worldwide (2). NoV is highly infectious, with transmission occur-
ring predominantly through person-to-person contact or by in-
gestion of fecally contaminated food or water (3). The majority of
NoV outbreaks reported in Ireland occur in health care settings
(4) and follow the pattern of winter seasonality demonstrated pre-
viously in the Northern Hemisphere (5).
NoV is a distinct genus of the familyCaliciviridae that contains
viruses with a positive-sense, polyadenylated RNA genome of ap-
proximately 7.5 kb. The genome of human NoV is organized into
three open reading frames (ORFs). An NoV recombination hot
spot has been identified close to theORF1-ORF2 junction (6), and
at least 22 NoV recombinants have been detected (7). The lack of
a proofreading ability of the RNA-dependent RNA polymerase
(RdRp) contributes to a high error rate of NoV genome transcrip-
tion, resulting in even greater genetic diversity (8). Five NoV
genogroups have been recognized (GI to GV) and may be subdi-
vided into at least 29 genotypes (9). However, NoVGII genotype 4
(GII.4) accounts for the majority of acute gastroenteritis out-
breaks characterized worldwide.
NoV is shed at high concentrations in the feces of infected
patients (108 to 1012 genomic copies per g) andmay be shed for up
to 8 weeks after symptoms have subsided (10). NoV particles may
be detected in feces of both symptomatic and asymptomatic indi-
viduals (10, 11) and thus are commonly present in wastewater
treatment plant (WWTP) effluents throughout the year (12, 13).
Shellfish harvest areas may be affected by the discharge of waste-
water, and oysters can accumulate NoV from the surrounding
waters through the process of filter feeding. Under European reg-
ulations (14), assessment of the sanitary quality of shellfish harvest
areas relies on the use of the bacterial indicator organism Esche-
richia coli. However, E. coli has been shown to be an inadequate
indicator of viral contamination (15), and numerous NoV out-
breaks have been caused by shellfish compliant with the current
regulations (16–18). Furthermore, a characteristic of shellfish-re-
lated outbreaks is the presence of multiple NoV GI and GII geno-
types in the feces of infected patients (19, 20), whereas outbreaks
in closed or semiclosed settings are generally associated with a
single GII genotype (3), most commonly GII.4 (21).
In the present study, we investigated NoV concentrations in
both influent and secondary treated effluent at a WWTP and in
oysters placed adjacent to the WWTP discharge pipe over a 13-
week period. In addition, the NoV concentrations/genogroups
detected were subsequently compared with the number of labora-
tory-confirmed gastroenteritis cases caused by NoV GI and GII
identified from outbreaks (community and food related) investi-
gated during that time. Finally, we characterized the NoV geno-
types detected during a 5-week period which had the highest NoV
concentrations in municipal wastewater.
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MATERIALS AND METHODS
Sample population. A WWTP providing secondary wastewater treat-
ment and serving a population equivalent of 91,600 was selected for this
study. The final effluent was discharged to coastal waters through a 420-
m-long outfall pipe submerged at a depth of 10 m. One-liter, 24-hour
composite samples of influent (n 13) and effluent (n 13) were taken
on a weekly basis from January to March (weeks 1 to 13) of 2010 and
analyzed for NoV GI and NoV GII by real-time quantitative reverse tran-
scription-PCR (RT-qPCR). Oysters (Crassostrea gigas) previously dem-
onstrated to be free of NoV contamination were suspended in mesh bags
1mbelow thewater surface and attached to a buoy anchored to the outfall
pipe. Oyster samples (n  13), each consisting of a minimum of 10 ani-
mals, were collected 5 days after the wastewater samples, on a weekly basis
(weeks 2 to 14). Oyster and wastewater samples were transported to the
laboratory within 2 h under chilled conditions (15°C). The greatest
concentrations of NoV in the influent and effluent wastewater samples
were detected between weeks 5 and 9 of 2010, and these samples were
selected for further molecular characterization. Oyster samples corre-
sponding to the selected wastewater samples (weeks 6 to 10) were also
included in the sequencing analysis.
Stool samples (n  2,734) received from symptomatic patients
throughout Ireland between January and March 2010 were analyzed for
the presence ofNoVRNA.Themajority of the sampleswere received from
health care settings. Stool samples received from representative outbreaks
(n  8) that occurred between weeks 5 and 10 of 2010 were molecularly
characterized. One NoV-positive stool sample was randomly selected per
NoV outbreak.
Preparation of wastewater concentrate and shellfish proteinase K
extract. A membrane filter adsorption-elution method was used for the
concentration of wastewater samples as previously described (12). Briefly,
40 ml of each wastewater sample was passed through a cellulose prefilter
(Millipore, Billerica, MA) placed directly on a negatively charged filter
(Millipore) with a 0.45-m pore size, using a vacuum pump system.
Twenty-five milliliters of 0.14 M NaCl was passed through the filters,
which were then placed in 4 ml of 50 mM glycine-NaOH buffer (pH 9.5)
and mixed for 20 min at 500 rpm. The virus eluate was transferred to an
Amicon Ultra-4 (50 kDa) (Millipore, Billerica, MA) centrifugal filter and
centrifuged at 4,000 g for 10min. The retentate was resuspended in 550
l of molecular biology-grade water, and the wastewater concentrate was
stored at20°C prior to RNA extraction.
Oyster samples were cleaned by rinsing under potable water and were
opened using a flame-sterilized shucking knife. For each sample, the di-
gestive tissues (DT) of 10 oysters were dissected and chopped, and 2 g was
transferred to a 50-ml tube containing 2 ml of 100 g ml1 proteinase K
solution (Sigma-Aldrich), followed by the addition of 50 l of Mengo
virus strain MC0 as an internal positive control to control for extraction
efficiency. This mixture was then incubated at 37°C with shaking for 60
min, followed by incubation at 60°C for 15min. Following centrifugation
at 3,000 g for 5min, the shellfish proteinase K extract (supernatant) was
stored at80°C prior to RNA extraction within 1 month.
RNA extraction procedure for shellfish and wastewater. Viral RNA
was extracted from 500l of either shellfish proteinase K extract or waste-
water concentrate by use of a NucliSENS miniMAG extraction platform
and NucliSENS magnetic extraction reagents (bioMérieux, Marcy
l’Etoile, France) according to the manufacturer’s instructions. An RNA
extraction negative control (molecular biology-gradewater) was included
with each batch of samples extracted. Viral RNAwas eluted into 100l of
elution buffer and stored at 80°C. Additionally, each shellfish sample
was extracted at three different dilutions of shellfish proteinase K extract
(undiluted, 1:2, and 4:1), using phosphate-buffered saline (Oxoid, Bas-
ingstoke, United Kingdom), and then eluted in 30 l of elution buffer
prior to the nested RT-PCR.
NoV GI and GII quantification using one-step RT-qPCR. A previ-
ously described RT-qPCR assay was used to detect and quantify bothNoV
GI and GII in the influent, effluent, and oyster samples (12). For NoV GI
analysis, previously described primers QNIF4 (22) and NV1LCR and
probeNVGG1p (23) were used, and forNoVGII analysis, primersQNIF2
(24) and COG2R (25) and probe QNIFS (24) were used. For the internal
positive control, primersMengo209 andMengo110 and probeMengo147
were the same as those described by Pintó et al. (26).
pGEM-3Zf() plasmids carrying NoV GI and GII target sequences
containing a restriction site (BamHI) to check for contamination (sup-
plied by Francoise S. Le Guyader, Ifremer, Nantes, France) were used to
enable quantification of NoV RNA, reported in copies per l. A log dilu-
tion series of GI and GII DNA plasmids (range, 1 101 to 1 105 copies
per l) was included in duplicate in each RT-qPCR run, and the number
of NoV RNA copies perl was determined. The limit of detection (LOD)
for NoV GI and GII was 20 genome copies g1 of DT and 25 genome
copies 100ml1 for shellfish and wastewater samples, respectively. All the
samples were assessed for RT-PCR inhibition by using external control
RNA (12). Samples with an amplification efficiency of 25% were not
accepted, and in such cases, the sample RNA was reanalyzed at a 1:10
dilution. All the samples were also assessed for extraction efficiency, using
aMengo virus as an internal process control. Samples with a1% extrac-
tion efficiency were accepted for inclusion in this study.
Molecular characterization and genotyping of NoV. A selection of
influent and effluent wastewater, oyster, and NoV outbreak samples re-
ceived between weeks 5 and 10 of 2010 were further characterized and
sequenced as follows. Eight microliters of RNA was treated with 1 U of
RNase-free DNase (Promega, United Kingdom) according to the manu-
facturer’s protocol. RT was performed in a 30-l reaction volume con-
taining a 1 mM concentration of each deoxynucleoside triphosphate
(dNTP), 10mMdithiothreitol, 0.75g of random hexamers, 33 U RNase
inhibitor, 300 U of SuperScript II reverse transcriptase (Invitrogen,
United Kingdom), and 4.5l Superscript II buffer as described previously
(27). RT was carried out at 42°C for 75 min, followed by an inactivation
step at 99°C for 5min. The first-round nested PCRmixture contained 5l
cDNA and final concentrations of 10mMTris-HCl (pH 8.3), 50mMKCl,
20 M (each) dNTPs, 2 M (each) primers, 2.5 mMMgCl2, and 2.5 U of
AmpliTaq DNA polymerase (Applied Biosystems). The primers used for
theNoVGI andNoVGII reactionswere primersCOG1F andG1-SKRand
primers COG2F and G2-SKR, respectively (25, 28). The first-round PCR
product (1 l) was subsequently added to 49 l of a reaction mixture
containing 10mMTris-HCl (pH 8.3), 50mMKCl, 20M(each) dNTPs,
0.4 M (each) primers, 2.5 mM MgCl2, and 2.5 U of AmpliTaq DNA
polymerase. In the nested RT-PCR, the primers used were GISKF and
GISKR for NoV GI and GIISKF and GIISKR for NoV GII (28). The PCR
was performed under the following conditions: an initial denaturation at
95°C for 5 min; 40 amplification cycles of denaturation at 95°C for 1 min,
annealing at 50°C for 1 min, and extension at 72°C for 2 min; and a final
extension of 72°C for 15 min. Amplified DNA fragments were purified
using Chroma Spin columns (Unitech), and products were cloned into
the pCR4-TOPO vector according to the protocol for a TOPOTA cloning
kit (Invitrogen). Approximately 4 to 6 clones were randomly selected for
DNA sequencing. PCR products were sequenced using a BigDye Termi-
nator v 3.1 ready reaction kit (Applied Biosystems) per themanufacturer’s
recommendations and were analyzed on an ABI Prism 310 genetic ana-
lyzer (Applied Biosystems).
Ten percent fecal suspensions were prepared in Star buffer (Roche)
and were extracted (350l) by use of anMDX automated extractor (Qia-
gen), using the QIAamp One-For-All protocol per the manufacturer’s
instructions. Brome mosaic virus (BMV) (0.05 pg l1) internal control
RNA was added to the lysis buffer prior to extraction. A multiplex real-
time RT-PCR was carried out using a Superscript III Platinum one-step
quantitative RT-PCR kit (Invitrogen) per the manufacturer’s instruc-
tions, with a 25-l reaction volume. The primer and probe sequences for
NoVwere taken from thework of Rolfe et al. (29) andKageyama et al. (25)
andwere used at concentrations of 400 nMand 80 nM for the primers and
probes, respectively. BMV was coamplified by use of in-house primers
and probes, at concentrations of 200 nMand 100 nM, respectively. Primer
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and probe sequences for BMVwere as follows: BMV F, 5=-CCT TTT TCA
CTG CTT GTT TCG AGA A-3=; BMV R, 5=-TTT CCG ATA GGC ACA
ATG AAC CT-3=; and BMV probe, 5=-NED-ACT GGC CCT GAA ATC-
NFQ (MGB) (Applied Biosystems).
Phylogenetic analysis. The NoV sequences were aligned with refer-
ence strains retrieved from GenBank (http://www.ncbi.nlm.nih.gov/Gen
Bank/) by using the ClustalW algorithm ofMegAlign software (DNAStar,
Inc., Madison, WI). The genotype nomenclature of the reference strains
was adopted from the online Norovirus Genotyping Tool (http://www
.rivm.nl/mpf/norovirus/typingtool; National Institute of Public Health
and the Environment, Netherlands). The length of the NoV genome re-
gion usedwas 282 bp forNoVGI (positions 5354 to 5645 ofNorwalk virus
M87661) and 269 bp for NoV GII (positions 5085 to 5353 of Lordsdale
virus X86557). NoV bovine strain Newbury GIII.2 was used as an out-
group strain in the phylogenetic analysis of NoVGI andGII, and theGII.3
strain Oberhausen AF53944 was used as an outgroup for GII.4 analysis.
A maximum likelihood phylogenetic tree was constructed using
PAUP*, version 4.0 (30). Modeltest was used to select the most appropri-
ate model of evolution, using the hierarchal likelihood ratio test (31). The
maximum likelihood phylogenetic tree was based on the TrNIG
model of substitution for NoV GI, the TrNefIG model for NoV GII,
and the K80Gmodel forNoVGII.4 (31). The reliability of the generated
treewas estimated by bootstrap analysis of 1,000 replicates of the sequence
alignment, using the neighbor-joining method.
Recombinant analysis. Detection of potential NoV GI and GII re-
combinant sequences was carried out using the RecombinationDetection
Program, version 4.14 (RDP4) (32), comprising the following programs:
RDP, GENECONV, BOOTSCAN, MaxChi, CHIMAERA, SISCAN, and
3SEQ. The default settings for each of the programs in RDP4 were used,
except for BOOTSCANand SISCAN,where awindow size of 40 and a step
size of 20 were used. The potential NoV recombinants were considered
putative recombinant sequences if they were detected by at least 3 differ-
ent programs.
Statistical analysis. The Anderson-Darling test for normal distribu-
tion was applied to each data set, and the NoV concentrations in waste-
waters and oysters were logarithmically (base 10) transformed to achieve
a normal distribution. Minitab statistical software, version 16 (Minitab
Inc., State College, PA), was used for the data analysis. The reductions
during thewastewater treatment process were calculated on aweekly basis
by using the following equation: log reduction  log(Ninf/Neff), where
Ninf is the concentration of NoV detected in influent wastewater andNeff
is the concentration of NoV detected in effluent wastewater.
Nucleotide sequence accession numbers. The GenBank accession
numbers for all sequences analyzed during this study are as follows:
JQ362499 to JQ362594 and JQ280400 to JQ280407.
RESULTS
NoV concentrations in influent, effluent, and oysters between
January andMarch 2010.NoVGI andGII were detected in influ-
ent, effluent, and oyster samples on all sampling occasions
throughout the sampling period. The mean NoV GI and GII con-
centrations detected in influent wastewaters were 3.93 and 4.58
log genome copies 100 ml1, respectively (Table 1). The mean
concentration of NoV GII was 0.66 log genome copies 100 ml1
higher than the mean concentration of NoV GI in influent waste-
water, and this difference was significant (paired t test; P 0.001).
The mean NoV GI and GII concentrations detected in effluent
wastewater were 3.01 and 3.44 log genome copies 100 ml1, re-
spectively, and were not statistically different (paired t test; P 
0.05). The mean concentrations of NoV GI and GII detected in
oyster samples were 4.43 and 4.84 log genome copies g1, respec-
tively, and this difference was statistically significant (paired t test;
P  0.005). The mean NoV GI and GII reductions during the
treatment process were 0.92 and 1.14 log genome copies 100ml1,
respectively.
Laboratory-confirmed cases of NoV gastroenteritis. During
the study period, NoV GI and GII RNAs were detected in 16 and
931 stool samples, respectively. A peak in laboratory-confirmed
cases occurred in week 7 of 2010, with 171 patient samples testing
positive for NoV GII (Fig. 1). The largest number of laboratory-
confirmed cases of NoV GI infection (n  4) were detected in
week 9 of 2010. Overall NoV GII cases were confirmed approxi-
mately 58.2 timesmore frequently thanNoVGI cases (P 0.001).
The highest NoV GII concentration was detected in influent
wastewater in week 6 of 2010 (2.20 105 copies 100ml1), which
preceded the peak of laboratory-confirmed cases involving NoV
GII, in week 7. In the influent, the highest concentration of NoV
GI (5.59 104 copies 100 ml1) was detected in week 7.
Multiple NoV genotypes detected in wastewater, oyster, and
stool samples. Following phylogenetic characterization of sam-
ples fromweeks 5 to 10, NoVGI sequences (n 73) were ascribed
to five different genotypes, namely,GI.1, GI.4, GI.5, GI.6, andGI.7
(Fig. 2), and NoV GII sequences (n 74) were ascribed to seven
genotypes, namely, GII.3, GII.4, GII.6, GII.7, GII.12, GII.13, and
GII.17 (Fig. 2). Among NoV GII.4 genotypes, three variants were
identified: 2006b, 2008, and 2010. NoV sequences with 100%
identity detected in the different samples were designated groups
A to E for NoV GI and groups F and G for NoV GII (Fig. 2).
NoV outbreaks (n 8) that occurred between weeks 5 and 10
of 2010 (Fig. 1) were genetically characterized and incorporated
into the phylogenetic analysis (Fig. 2). Outbreaks were associated
with NoV GII.4 variant 2010 (n  5), NoV GII.4 variant 2006b
(n 1), NoV GII.13 (n 1), and NoV GI.6 (n 1). A NoV GI.6
sequence (10IRL06528) (Fig. 2) associated with an outbreak that
occurred during week 9 had 100% sequence identity with NoV
sequences detected in effluent and oyster samples collected during
week 8 (group D) (Fig. 2).
Norovirus genotype patterns in wastewater and oysters. In
five samples of influent wastewater (n  25 sequences), the
most frequently detected NoV GI genotype was GI.7 (15/25
sequences [60.0%]), followed by GI.5 (5/25 sequences
[20.0%]), GI.4 (4/25 sequences [16.0%]), and GI.6 (1/25 se-
quences [4.0%]) (Fig. 3). In five samples of effluent wastewater
(n  25 sequences), NoV GI.4 was the most prevalent NoV GI
TABLE 1 Mean concentrations of NoV GI and GII in influent and effluent wastewaters and impacted oysters between January and March 2010
NoV genogroup
Mean concn SD (range)
Influenta Effluenta Oystersb
GI 3.93 0.44 (3.08–4.76) 3.01 0.63 (1.73–4.06) 4.43 0.45 (3.50–5.13)
GII 4.58 0.38 (3.98–5.34) 3.44 0.47 (2.34–3.99) 4.84 0.25 (4.39–5.23)
a Concentrations are expressed as log genome copies 100 ml1.
b Concentrations are expressed as log genome copies g1.
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genotype, detected in 44.0% of the sequences (11/25 se-
quences), followed by GI.7 (10/25 sequences [40.0%]) and GI.6
(4/25 sequences [16.0%]). In oyster samples, NoV GI.4 was
also the predominant NoV GI genotype (13/23 sequences
[56.5]), and the other genotypes identified were GI.6 (5/23
sequences [21.7%]), GI.7 (3/23 sequences [13.0%]), GI.5 (1/23
sequences [4.3%]), and GI.1 (1/23 sequences [4.3%]) (Fig. 3).
NoVGII.4 was the dominantNoVGII genotype detected (8/24
sequences [33.3%]) in influent wastewater, followed by GII.12
(6/24 sequences [25.0%]), GII.17 (4/24 sequences [16.7%]), GII.6
(3/24 sequences [12.5%]), GII.7 (2/24 sequences [8.3%]), and
GII.13 (1/24 sequences [4.2%]). In the effluent wastewater, the
dominant genotype of NoV sequences was GII.4 (13/24 sequences
[54.2%]), also followed byGII.6 (6/24 sequences [25.0%]), GII.12
(3/24 sequences [12.5%]), and GII.13 (2/24 sequences [8.3%]).
Genotypes GII.7 and GII.17 were not detected in the effluent,
despite being detected in the influent wastewater. In oysters, two
genotypes,GII.4 (10 sequences [38.5%]) andGII.12 (10 sequences
[38.5%]), were detected at the same frequency, followed by GII.3
(4 sequences [15.4%]) and GII.6 (2 sequences [7.7%]). Two ge-
notypes, NoV GI.1 and GII.3, were detected in oysters, but these
were not detected in wastewater samples (Fig. 3B).
Recombinant analysis. Four potential NoV recombinant
strains were identified following analysis by RDP4. A sequence
was considered to be a putative recombinant if a recombination
event was detected by at least 3 recombinant detection methods.
The parent genotype and putative recombinants detected were as
follows: GII.12/GII.4 2006b (recombinant EFFII03035), GII.4
2010/GII.13 (recombinant INFII03039), and GII.4 2010/GII.3
(recombinant OYSII09021) for NoV GII and GI.4/GI.6 for NoV
GI (Fig. 4). Potential parental sequences and possible recombina-
tion breakpoints are listed in Table 2.
DISCUSSION
In 2010, 1,789 NoV illness notifications were reported in Ireland.
This was the largest number of NoVnotifications compared to the
numbers in previous years. A particularly large number of NoV
notifications (1,309) was recorded between January and March
(1). In the first 3 months of 2010, increased numbers of NoV
infections were also reported in other parts of Europe, including
Scotland (33), England and Wales (34), and Belgium (35). High-
er-than-average NoV activity in epidemic years has been associ-
ated with cold, dry weather, lower population immunity, and the
emergence of new NoV GII.4 variants (36). The winter of 2009–
2010 (December to February) was the coldest winter since the
winter of 1962–1963 in Ireland, but it was drier and sunnier than
usual, as reported by Met Éireann (http://www.met.ie/).
The national peak of NoV GII infections, as judged by labora-
tory-confirmed cases, occurred approximately 1 week after the
highest concentration of NoV GII was detected in influent waste-
water. However, given that NoV shedding can commence before
the onset of clinical symptoms (10) and that there is a slight time
lag between infection and laboratory confirmation, it is likely that
the peak concentration of NoV GII in wastewater occurred con-
currently with the peak number of infections in the community.
Detection of elevatedNoVGII concentrations in wastewater prior
to higher-than-normal reports of NoV gastroenteritis has been
described previously (22). Few NoV GI-associated laboratory-
confirmed cases were reported compared to those involving NoV
GII, and 7 of a total of 16 cases occurred between weeks 9 and 10.
However, given the small number of overall NoV GI-associated
cases, it is not possible to determine whether this represented a
peak of infections.
Concentrations of NoV GII were significantly greater than
NoV GI concentrations detected in influent wastewater, indicat-
ing either a greater frequency of NoV GII-associated infections in
the community or greater virus shedding by NoV GII-infected
patients than byNoVGI-infected patients. During the wastewater
treatment process, both NoV GI and GII underwent comparable
reductions over the study period, and the achieved reductions
(approximately 1 log) are consistent with reductions in previously
reported studies (13, 37). Larger numbers of laboratory-con-
firmed cases of NoV GII infection were detected in the commu-
nity. It appears that the greater concentrations of NoV GII in the
influent wastewater were a result of NoVGII cases in the commu-
nity. Nevertheless, despite the small number of laboratory-con-
FIG 1 Laboratory-confirmedNoV cases andNoV concentrations in influent wastewater. The numbers of gastroenteritis cases attributed to NoVGI (black bars)
and NoV GII (white bars) are shown, along with concentrations of NoV GI (dashed line) and NoV GII (solid line) detected in influent wastewaters between
January and March 2010 (weeks 1 to 13). One NoV-positive stool sample per NoV outbreak was randomly selected for further sequencing analysis. Eight NoV
outbreaks were genetically characterized as follows: in week 5, one outbreak sequence, 10IRL03196, was identified as GII.4 2010; in week 6, two outbreak
sequences, 10IRL02653 and 10IRL02654, were identified as GII.4 2010; in week 7, outbreak sequences 10IRL04566 and 10IRL07388were identified as GII.4 2010,
10IRL03903 was identified as GII.13, and 10IRL05499 was identified as GII.4 2008; and in week 9, outbreak sequence 10IRL06528 was identified as GI.6.
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FIG2 Molecular characterization ofNoVGI (A) andGII (B) sequences detected inwastewater, oysters, and gastroenteritis outbreaks in Ireland between January
and March 2010. Phylogenetic trees were based on the partial capsid region of the NoV GI and GII genomes (282 and 269 bp, respectively). For NoV GII.4
sequences, a separate phylogenetic tree was built. All phylogenetic trees include bootstrap scores for branches, shown as percentages for 1,000 replicates
(bootstrap values of 70% are not shown). NoV sequences were named with the code “INF” (influent), “EFF” (effluent), or “OYS” (oysters) followed by xx
(sampling day) and xx (sampling month), followed by consecutive numbers used for laboratory differentiation. Identical sequences of NoV GI detected in
different samples were designated group A (influent sampled on weeks 5, 6, 7, and 8, effluent sampled on weeks 5 and 9, and oysters sampled on week 9), group
B (oysters fromweeks 6 and 8), groupC (influent fromweeks 7 and 9 and oysters fromweek 8), groupD (effluent fromweek 8 and oysters fromweek 8), or group
E (influent fromweeks 5 and 9). The NoVGI sequence detected in the NoV outbreak was labeled 10IRL06528. Identical NoVGII sequences detected in different
samples were designated group F (influent sampled onweeks 5 and 7 and effluent sampled onweek 8), groupG (effluent fromweeks 6 and 7), or groupH (oysters
from weeks 8 and 9). NoV GII sequences detected in the NoV outbreak were labeled 10IRL02653, 10IRL02654, 10IRL03196, 10IRL03903, 10IRL04566,
10IRL05499, and 10IRL07388. *, putative recombinant.
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firmed cases of NoV GI infection during the study period, rela-
tively high concentrations of NoV GI were detected in influent
wastewater, and concentrations peaked in week 7. This suggests
that during the study period, an increased number of community
infections associated with NoV GI occurred. Unless a significant
number of NoVGI-associated infections are asymptomatic, it ap-
pears that NoV GI-associated infections were underreported in
Ireland during this study period. The majority of stool samples
analyzed in this studywere obtained fromoutbreaks that occurred
in health care settings. Given the previously described prevalence
of NoV GII infections in such settings (3, 4), the large number of
laboratory-confirmed cases involving NoV GII was expected. It is
possible that NoV GI infections are underreported to public
health authorities more often than NoV GII infections due to
FIG 3 NoV genotype profiles detected in wastewater and oyster samples. NoV GI genotypes (A) and NoV GII genotypes (B) are shown as percentages of all
genotypes detected in either the influent or effluent wastewater or oyster samples.
FIG 4 BOOTSCAN evidence of recombination events. BOOTSCAN analysis was performed based on pairwise distance, with a window size of 40, a step size of
20, and 100 bootstrap replicates.
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sampling bias in health care settings, their more-varied transmis-
sion mode (3, 38), or the severity of illness (39).
NoV outbreaks were genetically characterized, and three
different genotypes were detected: GII.4 (variants 2010 and
2006b), GII.13, and GI.6. All of these NoV sequences were
highly similar to NoV sequences found in the influent waste-
water, effluent wastewater, and oysters. The newly emerged
GII.4 2010 variant (35, 40) was the most frequently detected
variant of GII.4 in the outbreaks as well as in the environmental
samples. The GII.4 2010 variant was first identified in France in
February 2009 (40), and it became the dominant GII.4 variant
in Europe during the winter of 2009–2010 (33, 35, 41). In the
United States, GII.4 2010 replaced GII.4 2006b as the predom-
inant variant in the winter of 2009–2010 (42, 43). GII.4 2010
gained a global distribution in 2009 and 2010, being detected in
Taiwan, China, Australia, Japan, India, Cameroon, and the
United States (BLAST search). It is clear that a similar GII.4
variant replacement took place in Ireland, as supported by the
high rates of detection in wastewater and of laboratory-con-
firmed cases of NoV infections reported in this study.
Interestingly, all of the NoV GII.12 sequences detected in
the environmental samples were highly similar to the recombi-
nant strain GII.g (polymerase)/GII.12 (capsid) St. George
(GenBank accession no. GQ845370) (44), which was reported
in a large number of non-GII.4 NoV outbreaks in the United
States (45, 46) and Europe (41) in the winter of 2009–2010.
However, this strain was not identified in any of the outbreak
samples analyzed in this study. It is possible that some of the
NoV genotypes frequently identified in the influent, the efflu-
ent, and impacted oysters, such as NoV GII.12, were responsi-
ble for infections in the community at the beginning of 2010
but were not detected due to limited sequencing carried out on
the outbreak samples.
The NoV genotype profiles detected in the influent, effluent,
and oyster samples varied. NoVGI.7 andNoVGI.4 were themost
frequently detected NoV GI genotypes from environmental sam-
ples during this study. This is consistent with the findings of the
Foodborne Viruses in Europe (FBVE) network, which reported
these genotypes as the most frequent causes of NoV GI outbreaks
throughout 2010 (41). In our study, NoV GI.7 was detected pre-
dominantly in the influent, less frequently in effluent wastewater,
and only sporadically in oyster samples. In contrast, NoVGI.4 was
the dominant genotype detected in effluent wastewater and oys-
ters. This is consistent with a previous study by this laboratory in
which NoV GI.4 was the predominant genotype detected in oys-
ters originating froma commercial harvest area (47). In this study,
the NoV GI.1 and GII.3 genotypes were absent in wastewater but
were detected in oyster samples, and this could possibly be linked
with their preferential accumulation in oyster tissues, which has
been reported previously (48).
Recent studies on virus-like particles (VLPs) have shown that
the overall virion structures of GI.1, GII.4, GII.10, GII.12, and
GV.1 VLPs are similar; however, differences in flexibility between
their P and S capsid domains can influence binding of VLPs to
monoclonal antibodies (49, 50). It has also been shown that NoV
GI.1 particles can bind specifically to a histo-blood group antigen
(HBGA)A-like ligand present in the oyster digestive tract, and this
binding facilitates accumulation within oysters (48). Therefore, it
is reasonable to suggest that someNoVgenotypesmay accumulate
in oysters more efficiently than others because of their binding
properties, which explains why some NoVs have been detected
more commonly in shellfish-related outbreaks (51).
We identified four putative NoV recombinants: GI.4/GI.6 and
GII.4 2010/GII.13 in the influent, GII.12/GII.4 2006b in the efflu-
ent, and GII.4 2010/GII.3 in the oysters. Although a short frag-
ment (291 bp for GI and 302 bp for GII) of the NoV genome was
used to identify recombinants, the detection of each recombinant
was supported by at least three detection methods available in
RDP4. The GII.4/GII.3 recombinant has been described previ-
ously by Vidal et al. (52); however, to our knowledge, the three
other recombinants detected here have not been identified before.
Most of the parental sequences identified, such asGI.6,GII.4 2010,
GII.4 2006b, and GII.13, were detected in the clinical samples
during this study. As the putative recombinants were detected in
the environmental samples only, it is not possible to comment on
their virulence. It has been shown experimentally (53) that a novel
murine NoV recombinant can exhibit different biological proper-
ties from those of its parental viruses. As oysters can accumulate
different NoV genotypes (including recombinants), the potential
exists for the reintroduction of these new or possibly more viru-
lentNoV strains to the humanpopulation through contamination
of oysters and their subsequent consumption.
In summary, we suggest that during this study, allowing for the
delay in laboratory confirmation, there were concurrent peaks in
NoV GII concentrations in wastewater and NoV infections in the
community in Ireland in February 2010. We demonstrated that a
diverse range of NoVGI genotypes were present in environmental
samples (wastewater and oysters), despite the fact that the over-
whelmingmajority of laboratory-confirmed cases were attributed
to NoV GII. Therefore, we suggest that the number of NoV GI-
associated infections may be underreported. Finally, different ge-
notype profiles were observed in influent wastewater and oysters,
possibly indicating differing survival characteristics through the
treatment process for different genotypes or preferential accumu-
lation of some genotypes in oysters.
TABLE 2 Recombination events with possible recombination breakpoints and P values for the different recombination detection methods
NoV
Recombinant
sequence
Breakpointa P value for detection methodb
Beginning End GENECONV BOOTSCAN MaxChi CHIMAERA SISSCAN 3SEQ
GII EFFII03035 Unidentified 152 (5236) 1.10 104 4.19 107 7.15 107 7.15 107 NS 6.55 1017
GII INFII03039 Unidentified 147 (5231) 4.29 103 9.29 106 2.72 106 2.68 106 NS 2.19 1013
GII OYSII09021 Unidentified 201 (5285) NS 1.01 104 5.02 106 4.95 106 NS 1.05 1013
GI INF03035 75 (5428*) 219 (5582*) NS 1.17 103 4.87 106 1.01 105 2.11 1012 2.60 1012
a Breakpoint position in alignment (breakpoint position relative to strain X86557 or M87661 [strain M87661 where marked with an asterisk]).
b NS, not significant.
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